Qwoted is a free expert network: we help reporters connect with experts & we help those same experts build relationships with top reporters.
Event Date |
Tue May 6 CDT (25 days ago)
In your timezone (EDT): Tue May 6 1:00am - Tue May 6 1:00am |
Location | Webinar |
Region | Americas |
GLP-1 medications are transforming the treatment of obesity, a challenge affecting millions of U.S. workers. Yet the high cost is a significant concern for companies looking to balance access with affordability. In this session, leaders from Noom will break down the GLP-1 cost cycle and identify ways organizations can provide affordable access to GLP-1s and other anti-obesity medications regardless of their coverage policies. You'll learn how the obesity crisis is affecting employers, the impact of GLP-1 compounds, and how Noom can help you confidently manage GLP-1 costs and achieve long-term return on investment.
From Day One is a Recertification Provider for SHRM and HRCI. This session is eligible for 1 PDC. The Activity ID will be sent to attendees after the conclusion of the session.
This session is hosted by the From Day One editorial team with support from Noom Health.
2025 Speakers
Kelly Bourdet
Founder, Apparata Media
Cody Fair
Chief Commercial Officer, Noom
Jennifer Jones
Director, Clinical Solutions Architect, Noom
2025 Partner
• Noom Health